Literature DB >> 17562930

Accuracy of the clinical evaluation for frontotemporal dementia.

Mario F Mendez1, Jill S Shapira, Aaron McMurtray, Eliot Licht, Bruce L Miller.   

Abstract

BACKGROUND: Without a definitive clinical test, the early diagnosis of frontotemporal dementia (FTD) can be difficult.
OBJECTIVE: To evaluate the accuracy of the clinical evaluation for FTD.
DESIGN: Retrospective assessment of consensus criteria for FTD, neuropsychological measures, magnetic resonance images, and single-photon emission computed tomography/positron emission tomography (SPECT/PET) scans at baseline compared with a standard of subsequent clinical diagnosis after follow-up and reevaluation to year 2.
SETTING: University hospital. PATIENTS: A total of 134 patients referred for clinical evaluation of suspected FTD. These patients had 1 or more core or supportive features of FTD in the absence of another etiology on initial assessment. MAIN OUTCOME MEASURES: Sensitivities, specificities, and predictive values of consensus criteria for FTD, magnetic resonance images, and SPECT/PET scans at initial assessment.
RESULTS: The sensitivities and specificities for the diagnosis of FTD were 36.5% and 100.0% for consensus criteria, 63.5% and 70.4% for magnetic resonance images, and 90.5% and 74.6% for SPECT/PET scans, respectively. With a previous prevalence of nearly 50% for FTD, the positive predictive value was greatest for consensus criteria (100.0%), and the negative predictive value was greatest for SPECT/PET (89.8%). The initial neuropsychological results did not distinguish FTD, but the pattern of progression (worse naming and executive functions and preserved constructional ability) helped establish the diagnosis at year 2.
CONCLUSIONS: Consensus criteria for FTD and neuropsychological measures lacked sensitivity for FTD; however, neuroimaging, particularly functional brain studies, greatly increased the sensitivity of detecting FTD. The clinical diagnosis of FTD needs to combine neuropsychiatric features with SPECT or PET findings while following the changes on neuropsychological tests.

Entities:  

Mesh:

Year:  2007        PMID: 17562930     DOI: 10.1001/archneur.64.6.830

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  61 in total

1.  CSF metabolites in the differential diagnosis of Alzheimer's disease from frontal variant of frontotemporal dementia.

Authors:  Francesca de Rino; Filippo Martinelli-Boneschi; Francesca Caso; Marta Zuffi; Matteo Zabeo; Gabriella Passerini; Giancarlo Comi; Giuseppe Magnani; Massimo Franceschi
Journal:  Neurol Sci       Date:  2011-11-29       Impact factor: 3.307

2.  Psychiatric conditions that can mimic early behavioral variant frontotemporal dementia: the importance of the new diagnostic criteria.

Authors:  Facundo Manes
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

3.  Frontotemporal Dementia and Psychiatric Illness: Emerging Clinical and Biological Links in Gene Carriers.

Authors:  Nikolas R Block; Sharon J Sha; Anna M Karydas; Jamie C Fong; Mary G De May; Bruce L Miller; Howard J Rosen
Journal:  Am J Geriatr Psychiatry       Date:  2015-06-21       Impact factor: 4.105

Review 4.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

5.  Brain 18FDG-PET pattern in patients with alcohol-related cognitive impairment.

Authors:  Virgile Clergue-Duval; Frank Questel; Julien Azuar; Claire Paquet; Emmanuel Cognat; Jihed Amami; Mathieu Queneau; Alexandra Dereux; Thomas Barré; Frank Bellivier; Karim Farid; Florence Vorspan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-19       Impact factor: 9.236

6.  How much do physicians in Latin America know about behavioral variant frontotemporal dementia?

Authors:  Ezequiel Gleichgerrcht; Daniel Flichtentrei; Facundo Manes
Journal:  J Mol Neurosci       Date:  2011-05-25       Impact factor: 3.444

7.  Comparison of grey matter and metabolic reductions in frontotemporal dementia using FDG-PET and voxel-based morphometric MR studies.

Authors:  Tomonori Kanda; Kazunari Ishii; Takafumi Uemura; Naokazu Miyamoto; Toshiki Yoshikawa; Atsushi K Kono; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-07-26       Impact factor: 9.236

Review 8.  Diagnosis and management of behavioral issues in frontotemporal dementia.

Authors:  Masood Manoochehri; Edward D Huey
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 9.  Management of frontotemporal dementia in mental health and multidisciplinary settings.

Authors:  Mary Anne Wylie; Adriana Shnall; Chiadi U Onyike; Edward D Huey
Journal:  Int Rev Psychiatry       Date:  2013-04

Review 10.  Clinical diagnostic criteria and classification controversies in frontotemporal lobar degeneration.

Authors:  Katya Rascovsky; Murray Grossman
Journal:  Int Rev Psychiatry       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.